Viewing Study NCT02959060


Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2026-01-05 @ 5:35 PM
Study NCT ID: NCT02959060
Status: COMPLETED
Last Update Posted: 2017-01-06
First Post: 2016-11-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics of BMS-986177 in Healthy Subjects
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module